AbbVie Profit Margin 2010-2018 | ABBV

Current and historical gross margin, operating margin and net profit margin for AbbVie (ABBV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AbbVie net profit margin as of December 31, 2018 is 17.36%.
AbbVie Annual Profit Margins
AbbVie Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $116.045B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $373.460B 16.93
Pfizer (PFE) United States $234.364B 13.12
Merck (MRK) United States $201.486B 17.22
Novartis AG (NVS) Switzerland $179.764B 15.53
Eli Lilly (LLY) United States $122.227B 21.22
Novo Nordisk (NVO) Denmark $118.193B 19.12
Sanofi (SNY) France $104.035B 12.84
GlaxoSmithKline (GSK) United Kingdom $99.050B 13.01
AstraZeneca (AZN) United Kingdom $98.074B 11.19
Bristol-Myers Squibb (BMY) United States $72.907B 11.21